剂量表对加纳轮状病毒疫苗性能的影响
相关实验视频
Updated: Jun 16, 2026

09:04
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
12.5K
Ernest O Asare1,2, Mohammad A Al-Mamun3, George E Armah4
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
Science advances
|December 11, 2024
概括
在加纳优化轮状病毒疫苗 (RV1) 计划可以显著减少轮状病毒疾病. 像1/6/10周或6/10/14周这样的计划提供了更好的保护,第三剂可能可以防止更多的死亡.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 儿童传染病 儿童传染病
- 公共卫生建模公共卫生建模
背景情况:
- 罗塔病毒仍然是全球婴儿腹疾病的主要原因.
- 目前的轮状病毒疫苗 (RV1) 剂量计划可能无法在所有情况下实现最佳有效性.
- 加纳此前实施了6/10周的RV1时间表,为进一步分析提供了基础.
研究的目的:
- 为了量化加纳6/10周Rotarix (RV1) 疫苗计划的影响.
- 模拟替代RV1剂量计划对减少轮状病毒疾病的有效性.
- 评估额外的疫苗剂量的潜在影响.
主要方法:
- 利用数学建模方法来估计轮状病毒疾病的减少.
- 将实施的6/10周时间表与其他时间表进行比较 (例如1/6/10周,6/10/14周).
- 评估了加纳医院和国家一级的疫苗影响.
主要成果:
- 与没有接种疫苗相比,6/10周的RV1计划显著减少了轮状病毒病例.
- 其他方案,特别是1/6/10周和6/10/14周,显示了同等或更高的减少.
- 预计RV1的第三剂量可以预防额外的9-14%的轮状病毒死亡.
结论:
- 调整RV1剂量表可以提高加纳的疫苗性能.
- 1/6/10周和6/10/14周的计划似乎是最有效的.
- 额外的RV1剂量是改善轮状病毒控制的可行策略,特别是在疫苗有效性较低的地区.
相关概念视频
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

